{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The Food and Drug Administration yesterday approved over-the-counter sales of Prilosec, the little purple ulcer and heartburn pill that not long ago was the top-selling prescription medicine in the world. The decision benefits those who pay for the drug -- health insurers and people with no insurance -- and could roil the pharmaceutical industry. Prilosec is expected to sell for less than $1 a pill when it becomes available without a prescription this fall, compared with $4 a pill now. But few consumers who have health insurance will see any savings, because many managed care plans will stop paying for the drug altogether, health care executives said.", "headline": {"main": "F.D.A. Approves Over-Counter Sales Of Top Ulcer Drug"}, "abstract": "Food and Drug Administration approves over-the-counter sales of Prilosec, top-selling prescription medicine for ulcers and heartburn; Prilosec, made by AstraZeneca, is expected to sell for less than $1 a pill this fall, compared with $4 a pill now; few consumers with health insurance will see any savings since plans do not cover over-the-counter drugs; people without insurance or on Medicare, which does not cover prescription drugs, stand to save hundreds of dollars a year; health insurers may respond by making similar prescription drugs, like Nexium, Prevacid, Protonix and Aciphex, more expensive or harder to obtain; Prilosec and similar drugs, known as proton-pump inhibitors, had $13 billion in sales last year, more than any other class of drugs; photo; chart (L)", "print_page": "1", "word_count": 1362, "_id": "4fd2437f8eb7c8105d7dd127", "snippet": "The Food and Drug Administration yesterday approved over-the-counter sales of Prilosec, the little purple ulcer and heartburn pill that not long ago was the top-selling prescription medicine in the world. The decision benefits those who pay for the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/06/21/business/fda-approves-over-counter-sales-of-top-ulcer-drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "ASTRAZENECA"}, {"name": "subject", "value": "SALES"}, {"name": "subject", "value": "HEARTBURN"}, {"name": "subject", "value": "ULCERS"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "NEXIUM (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "PREVACID (DRUG)"}, {"name": "subject", "value": "PROTONIX (DRUG)"}, {"name": "subject", "value": "ACIPHEX (DRUG)"}, {"name": "subject", "value": "PRILOSEC (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gardiner", "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2003-06-21T00:00:00Z", "section_name": "Front Page; Health; Business"}, {"type_of_material": "Summary", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Prilosec to Be Available Without a Prescription The Food and Drug Administration approved over-the-counter sales of Prilosec, the ulcer and heartburn pill that not long ago was the top-selling prescription medicine in the world. The decision benefits those who pay for the drug -- health insurers and people with no insurance -- and could roil the pharmaceutical industry. Prilosec is expected to sell for less than $1 a pill when it becomes available without a prescription this fall, compared with $4 a pill now. But health care executives said that few consumers who have health insurance would see any savings. [Page A1.]", "headline": {"main": "BUSINESS DIGEST"}, "abstract": null, "print_page": "1", "word_count": 556, "_id": "4fd22a078eb7c8105d7b409c", "snippet": "Prilosec to Be Available Without a Prescription  The Food and Drug Administration approved over-the-counter sales of Prilosec, the ulcer and heartburn pill that not long ago was the top-selling prescription medicine in the world. The decision...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/06/21/business/business-digest-207446.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "2003-06-21T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Express Scripts Inc., which manages prescription-drug benefits for employers and insurers, is under investigation by the New York State attorney general, Eliot Spitzer, on suspicions of overbilling state health plans. Shares of Express Scripts fell $2.53, or 3.6 percent, to $66.89 in Nasdaq trading after the company disclosed a subpoena from Mr. Spitzer in a filing to the Securities and Exchange Commission. Mr. Spitzer is examining the company's pricing policies, the attorney general's spokesman, Darren Dopp, said. The company, which is based in Maryland Heights, Mo., said in its filing that Mr. Spitzer's inquiry deals with ''state and federal antitrust and consumer protection laws,'' and that its practices comply with those laws.", "headline": {"main": "STATE OF NEW YORK OPENS INQUIRY ON EXPRESS SCRIPTS", "kicker": "COMPANY NEWS"}, "abstract": "New York State Atty Gen Eliot Spitzer opens investigation of prescription drug manager Express Scripts Inc on suspicion that company overbilled state health plans (S)", "print_page": "5", "word_count": 114, "_id": "4fd22c548eb7c8105d7b82f7", "snippet": "Express Scripts Inc., which manages prescription-drug benefits for employers and insurers, is under investigation by the New York State attorney general, Eliot Spitzer, on suspicions of overbilling state health plans. Shares of Express Scripts fell...", "source": "Bloomberg News", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/06/21/business/company-news-state-of-new-york-opens-inquiry-on-express-scripts.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "SPITZER, ELIOT L"}, {"name": "glocations", "value": "NEW YORK STATE"}, {"name": "organizations", "value": "EXPRESS SCRIPTS INC"}, {"name": "subject", "value": "FRAUDS AND SWINDLING"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": null, "document_type": "article", "pub_date": "2003-06-21T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "AstraZeneca, the large pharmaceutical company, pleaded guilty today to a felony charge of health care fraud and agreed to pay $355 million to settle criminal and civil accusations that it engaged in a nationwide scheme to illegally market a prostate cancer drug. The government said the company's employees had given illegal financial inducements to as many as 400 doctors across the country to persuade them to prescribe the drug, Zoladex. Those inducements included thousands of free samples of Zoladex, worth hundreds of dollars each, which the physicians then billed to Medicare and other federal health care programs, prosecutors said. The company also gave doctors financial grants, paid them as consultants and provided free travel and entertainment, the government said.", "headline": {"main": "AstraZeneca Pleads Guilty In Cancer Medicine Scheme"}, "abstract": "British pharmaceutical maker AstraZeneca pleads guilty to health care fraud in case involving prostate cancer drug Zoladex; will pay total of $355 million, which includes $64 million criminal fine, $291 million to settle most civil accusations and $25 million to settle accusations of fraud against Medicare; company admits it gave doctors free samples of Zoladex knowing that government would be billed, but disputes charge that it inflated price of Zoladex reported for Medicare reimbursement; chart; photo (M)", "print_page": "1", "word_count": 960, "_id": "4fd274038eb7c8105d83186c", "snippet": "AstraZeneca, the large pharmaceutical company, pleaded guilty today to a felony charge of health care fraud and agreed to pay $355 million to settle criminal and civil accusations that it engaged in a nationwide scheme to illegally market a prostate...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/06/21/business/astrazeneca-pleads-guilty-in-cancer-medicine-scheme.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "MEDICARE"}, {"name": "organizations", "value": "ASTRAZENECA"}, {"name": "subject", "value": "FRAUDS AND SWINDLING"}, {"name": "subject", "value": "FINES (PENALTIES)"}, {"name": "subject", "value": "ZOLADEX (DRUG)"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "PROSTATE GLAND"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "DOCTORS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By MELODY PETERSEN"}, "document_type": "article", "pub_date": "2003-06-21T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Senate voted overwhelmingly today to let pharmacists import prescription drugs from Canada and resell them in the United States, so consumers here could benefit from lower Canadian prices. It was the second time in less than a year that the Senate had taken such a stand. But the proposal is contingent on a finding that the imports would pose no risk to public health, and the Bush administration has made clear that it will not issue such a finding.", "headline": {"main": "Senate Votes Again to Allow Importing of Drugs From Canada"}, "abstract": "US Senate votes, 62 to 28, to allow pharmacists to import prescription drugs from Canada, contingent on finding that such imports would pose no risk to public health; Bush administration has made it clear that it will not issue such a finding; photo (M)", "print_page": "13", "word_count": 718, "_id": "4fd291678eb7c8105d86a189", "snippet": "The Senate voted overwhelmingly today to let pharmacists import prescription drugs from Canada and resell them in the United States, so consumers here could benefit from lower Canadian prices.    It was the second time in less than a year that the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/06/21/us/senate-votes-again-to-allow-importing-of-drugs-from-canada.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "CANADA"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2003-06-21T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "In the pageant of inaction that was New York's regular legislative session, Exhibit A was Albany's failure to pass a law to shed light on the inner workings of government. It was only days ago, on Sunday, that Gov. George E. Pataki pledged to tighten the state's lobbying laws, thereby vying with the two top legislative leaders for the mantle of government reformer.", "headline": {"main": "A Long Night and Day In a Year of Very Little", "kicker": "ENDGAME IN ALBANY: LEGISLATION"}, "abstract": "New York State legislators meet in days before end of regular legislative session, trying to reach agreement on many proposed reforms for this year; photo (M)", "print_page": "7", "word_count": 1148, "_id": "4fd2422c8eb7c8105d7dabf4", "snippet": "In the pageant of inaction that was New York's regular legislative session, Exhibit A was Albany's failure to pass a law to shed light on the inner workings of government.    It was only days ago, on Sunday, that Gov. George E. Pataki pledged to...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/06/21/nyregion/endgame-in-albany-legislation-a-long-night-and-day-in-a-year-of-very-little.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW YORK STATE"}, {"name": "subject", "value": "POLITICS AND GOVERNMENT"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Al", "lastname": "BAKER"}], "original": "By AL BAKER"}, "document_type": "article", "pub_date": "2003-06-21T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "The battered and disfigured Deutsche Bank building in Lower Manhattan, among the last remaining buildings damaged in the Sept. 11 terrorist attack whose fate has not been decided, has been deemed beyond repair and is expected to be taken down beginning next month, according to people involved in negotiations on its future. It will be the end of an unlikely symbol. In the days immediately after Sept. 11, 2001, the boxy, 40-story skyscraper next to the ruined World Trade Center became a talisman of hope to many rescue workers at ground zero. Human remains were found on its roof.", "headline": {"main": "Last Days For a Survivor Of Sept. 11"}, "abstract": "Last Days For aa", "print_page": "1", "word_count": 1042, "_id": "4fd243308eb7c8105d7dcb8d", "snippet": "The battered and disfigured Deutsche Bank building in Lower Manhattan, among the last remaining buildings damaged in the Sept. 11 terrorist attack whose fate has not been decided, has been deemed beyond repair and is expected to be taken down...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/06/20/nyregion/last-days-for-a-survivor-of-sept-11.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "TERRORISM"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Edward", "lastname": "WYATT"}, {"firstname": "Charles", "middlename": "V.", "lastname": "BAGLI", "rank": 2, "role": "reported", "organization": ""}], "original": "By EDWARD WYATT and CHARLES V. BAGLI"}, "document_type": "article", "pub_date": "2003-06-20T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Senate overwhelmingly approved a proposal today to give consumers swifter access to low-cost copies of brand-name prescription drugs. It also turned back a Democratic effort to limit the premiums that could be charged for new prescription drug benefits under Medicare.", "headline": {"main": "Senate Votes to Give Consumers Faster Access to Generic Drugs, Amending Medicare Bill"}, "abstract": "Senate, 94-1, approves Gregg-Schumer amendment l to give consumers faster access to lower-cost generic versions of prescription drugs; turns down, 56-39, Democratic effort to limit premiums that could be charged for new drug benefits under Medicare; White House signals general support but criticizes bipartisan compromise authorizing government to deliver drug benefits in areas where private insurers do not offer coverage; 27 Republican senators, mostly conservatives, tell White House of concerns about estimated cost of $400 billion over ten years (M)", "print_page": "18", "word_count": 894, "_id": "4fd2740b8eb7c8105d831c55", "snippet": "The Senate overwhelmingly approved a proposal today to give consumers swifter access to low-cost copies of brand-name prescription drugs.    It also turned back a Democratic effort to limit the premiums that could be charged for new prescription drug...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/06/20/us/senate-votes-give-consumers-faster-access-generic-drugs-amending-medicare-bill.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "persons", "value": "GREGG, JUDD"}, {"name": "persons", "value": "SCHUMER, CHARLES E"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Robin", "lastname": "TONER"}], "original": "By ROBERT PEAR and ROBIN TONER"}, "document_type": "article", "pub_date": "2003-06-20T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The Justice Department filed a lawsuit yesterday to shut down what it said was a fraudulent scheme to take the corporate concept of acquiring a mailbox in Bermuda to avoid taxes and apply it to individuals. Corporations can, by complex maneuvers, in effect renounce America to avoid taxes on profits earned in the United States. Individuals can do the same if they leave the country. Congress taxes all individuals living in the United States, with minor exceptions, and American citizens regardless of where they live.", "headline": {"main": "U.S. Moves Against Promoter Of Tax-Avoidance Maneuver"}, "abstract": "Justice Department file lawsuit to shut down what is says is fraudulent scheme to take corporate concept of acquiring mailbox in Bermuda to avoid taxes and apply it to individuals; corporations can, by complex manuevers, in effect renounce America to avoid taxes on profits earned in US; individuals can do same if they leave country; suit claims Take Back America Foundation engaged in tax fraud by selling several thousand Americans packages that foundation says allows them to renounce their citizenship, stay in US and then restore their citizenship in way that frees them from owing income, Social Security and Medicare taxes; foundation is run by Austin Gary Cooper and his wife, Martha (M)", "print_page": "14", "word_count": 462, "_id": "4fd243308eb7c8105d7dcb95", "snippet": "The Justice Department filed a lawsuit yesterday to shut down what it said was a fraudulent scheme to take the corporate concept of acquiring a mailbox in Bermuda to avoid taxes and apply it to individuals.    Corporations can, by complex maneuvers,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/06/20/business/us-moves-against-promoter-of-tax-avoidance-maneuver.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "BERMUDA"}, {"name": "organizations", "value": "JUSTICE DEPARTMENT"}, {"name": "organizations", "value": "TAKE BACK AMERICA FOUNDATION"}, {"name": "subject", "value": "FRAUDS AND SWINDLING"}, {"name": "subject", "value": "TAX EVASION"}, {"name": "subject", "value": "CITIZENSHIP"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "TAXATION"}, {"name": "subject", "value": "SOCIAL SECURITY (US)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "CORPORATIONS"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "TAX SHELTERS"}], "byline": {"person": [{"firstname": "David", "middlename": "Cay", "lastname": "JOHNSTON", "rank": 1, "role": "reported", "organization": ""}], "original": "By DAVID CAY JOHNSTON"}, "document_type": "article", "pub_date": "2003-06-20T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "As the last day of the regular legislative session wore on this morning, Gov. George E. Pataki and legislative leaders had not yet reached agreements on a host of major bills, among them one to extend rent regulations. It appeared that the 2003 session was in danger of being notable as much for what had not been done as for what had been done. The long night of strained and often fruitless negotiations capped a contentious six months in which the Legislature passed a budget over the governor's vetoes. Many legislators said the wounds from that conflict had yet to heal and ill feelings hindered compromise.", "headline": {"main": "Time Running Out, Albany Is Stymied On Major Measures"}, "abstract": "New York Gov George E Pataki and legislative leaders, facing final day of regular legislative session, fail to reach agreement on host of mjaor bills, among them one to extend rent regulations; Pataki and colleagues in Senate majority throw all-night negotiations into turmoil by passing surprise bill that would extend rent regulations for eight years; meanwhile, Assembly Democrats pass two versions of their own bill, one a four-year extension and other a one-year extension; it remains unclear how impasse will be resolved as current regulations expire; so many issues remain open that Assembly leaders say they plan to return later in morning, but Senate says it will finish its business before daybreak and adjourn for summer, leaving open possibility that Legislature will have unfinished business to resolve in fall; array of pending bills discussed; photos (M)", "print_page": "1", "word_count": 1352, "_id": "4fd2740b8eb7c8105d831c50", "snippet": "As the last day of the regular legislative session wore on this morning, Gov. George E. Pataki and legislative leaders had not yet reached agreements on a host of major bills, among them one to extend rent regulations. It appeared that the 2003...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/06/20/nyregion/time-running-out-albany-is-stymied-on-major-measures.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "PATAKI, GEORGE E"}, {"name": "glocations", "value": "NEW YORK STATE"}, {"name": "subject", "value": "HOUSING"}, {"name": "subject", "value": "RENTING AND LEASING"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "RENT CONTROL AND STABILIZATION"}], "byline": {"person": [{"qualifier": "Jr", "firstname": "James", "middlename": "C.", "lastname": "McKINLEY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JAMES C. McKINLEY Jr"}, "document_type": "article", "pub_date": "2003-06-20T00:00:00Z", "section_name": "Front Page; New York and Region"}], "meta": {"hits": 34, "offset": 0, "time": 61}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}